ISIN: XS3068786626

3x Long Eli Lilly

NAV as of 21 Oct 2026, 12:00 AM UTC

$54.72 (-3.06%)

Year-To-Date Change

8.05%

LSE
Borsa Italiana

Capital at risk. NAV calculated by Leverage Shares. For more information on the calculation please click here

More Leverage Factors:

Overview

What is the 3x Long Eli Lilly ETP?

The Leverage Shares 3x Long Eli Lilly (LLY) ETP (ISIN XS3068786626) is an exchange traded product (ETP) that seeks to deliver three times (3x) the daily performance of Eli Lilly and Company. It achieves leverage through margin borrowing and has physical ownership of the underlying, so it does not use swaps or other derivatives to achieve its exposure, and it does not have credit risk. Exposure is rebalanced daily, and an intraday rebalance mechanism ("airbag") is designed to cushion the largest intra-day moves, triggering at 16.67%. You cannot lose more than the amount you invest. The Leverage Shares 3x Long Eli Lilly (LLY) ETP has an annual management fee of 0.75% and is listed on the following exchanges: London Stock Exchange, Borsa Italiana. It is designed for short term trading and should be monitored daily.

ETP objective

To seek daily investment results, before fees and expenses, that correspond to 300% (3x) the daily performance of the underlying stock (LLY).

Who is this product for?

Sophisticated investors and active traders seeking to magnify short-term bullish views or tactically hedge positions, via transparent leverage and without a margin account.

*However, these are complex products.

Value of Underlying Assets

$2,134,860

or 1,680 shares of LLY

AUM

$711,394

or 13,000 shares of LLY3

Liabilities

$1,423,466

Listings & Tickers

Exchange	Base Currency	Trading Currency	Exchange Code	ISIN	SEDOL	BBG Ticker	WKN	Listing Date
London Stock Exchange	USD	USD	LLY3	XS3068786626	BP7M8M1	LLY3 LN	N/A	16 Sep 2025
London Stock Exchange	USD	GBP	3LLY	XS3068786626	BP7M8N2	3LLY LN	N/A	16 Sep 2025
Borsa Italiana	USD	EUR	LLY3	XS3068786626	BP7M951	LLY3 IM	N/A	22 Oct 2025

Key Facts

Index Details

Index Name: Euronext 3x Long Eli Lilly and Company
Index Provider: Euronext

Index Bloomberg Ticker: E3XLE
Leverage Factor: 3x

Net Asset Value

NAV (as of 21 Oct 2026): $54.72
Daily Return (% NAV change): -3.06%

Daily Change (of NAV): $-1.73

Structure

Structure: ETP
Domicile: Ireland
Replication Method: Physical

Dividends: Reinvested
Underlying Asset: LLY
Target Weights
Rebalance Frequency

Fees

Annual Management Fee: 0.75%
Interest Paid On Cash Balances

Performance Fee
Stock Borrow Rate

Tax & Legal

ISA: Eligible
SIPP: Eligible

UK Fund Reporting Status: Yes (effective 01/01/2026)
US IRS Sec 871(m): Not applicable

Passported Countries:

United Kingdom

Italy

Germany

France

Spain

Netherlands

Ireland

Poland

Belgium

Sweden

Norway

Austria

* The information on this website regarding UK Fund Reporting Status is accurate as of the stated effective date (the "Effective Date"). Leverage Shares makes no representation or warranty that such information will remain accurate, complete or current thereafter, assumes no obligation to update it, and, to the fullest extent permitted by applicable law, accepts no responsibility or liability for any inaccuracies or omissions arising after the Effective Date.

Key Services Providers

Issuer: Leverage Shares plc
Arranger: Leverage Shares Management Company Limited
Trustee: Apex Corporate Trustees (UK) Limited
Issuing and Paying Agent: U.S. Bank Europe DAC
Registrar: U.S. Bank Europe DAC
Portfolio Administrators: Flexinvest Limited
Stock Borrowing Provider and Custodian: Interactive Brokers LLC and/or Morgan Stanley & Co. LLC and/or Pershing LLC
Determination Agent: Calculation Agent Services LLC
Initial Authorised Participant: BNP Paribas Arbitrage S.N.C.,Virtu Financial Ireland Limited, Flow Traders and others
Sponsor

Fact Sheet

Final Terms CBI Final Terms FCA

2026-10 EN DE ES FR IT NL PL SV

2026-09 EN DE ES FR IT NL PL SV

2026-08 EN DE ES FR IT NL PL SV

2026-07 EN DE ES FR IT NL PL SV

2026-06 EN DE ES FR IT NL PL SV

2026-05 EN DE ES FR IT NL PL SV

2026-04 EN DE ES FR IT NL PL SV

2026-03 EN DE ES FR IT NL PL SV

2026-02 EN DE ES FR IT NL PL SV

2026-01 EN DE ES FR IT NL PL SV

2025-12 EN DE ES FR IT NL PL SV

2025-11 EN DE ES FR IT NL PL SV

2025-10 EN DE ES FR IT NL PL SV

2025-09 EN DE ES FR IT NL PL SV

Reportable Income EMT Supplemental Trust Deeds

Supplement (CBI) 07 July 2026 Supplement (FCA) 07 July 2026 Prospectus (CBI) 11 June 2026 Prospectus (FCA) 09 June 2026 Prospectus (CBI) 13 March 2026 Prospectus (FCA) 13 March 2026 Prospectus (CBI) 23 June 2025 Prospectus (FCA) 23 June 2025 Prospectus (CBI) 17 July 2024 Prospectus (FCA) 17 July 2024 Prospectus (CBI) 15 March 2024 Prospectus (FCA) 15 March 2024 Prospectus (CBI) 18 October 2023 Prospectus (FCA) 18 October 2023 Prospectus (CBI) 04 May 2023 Prospectus (FCA) 04 May 2023 Supplement 01 June 2022 Prospectus 16 May 2022 Prospectus 07 December 2021 Supplement 08 October 2021 Supplement 17 September 2021 Supplement 06 May 2021 Supplement 04 March 2021 Prospectus 18 December 2020 Prospectus 06 November 2020 Prospectus 05 February 2020

Notices

Latest Notice

18.09.2026 Batch Notification 11.09.2026 Notice Appointment of Authorised Participants 26.08.2026 Notification of New Series 21.07.2026 Batch Notification 19.06.2026 Notice to ETP Securityholders 03.06.2026 Notices of Investment Strategy Modifications 21.05.2026 Batch Notification 30.04.2026 Notification of New Series 24.03.2026 Notification of New Series 23.03.2026 Batch Notification 11.03.2026 Notices of Investment Strategy Modifications 31.10.2025 Notice of Publication of Audited Financial Statements 20.10.2025 Notice of Cross Listing on Borsa Italiana 02.11.2023 Notice of Late Filing of Audited Financial Report 19.10.2023 Notice to ETP Securityholders 20.09.2023 Notice of Migration to IB LLC 04.05.2023 Notice of Amended and Restated Conditions

Frequently Asked Questions about the 3x Long Eli Lilly (LLY) ETP

Expand All

What is the 3x Long Eli Lilly (LLY) ETP?

The Leverage Shares 3x Long Eli Lilly (LLY) ETP has an annual management fee of 0.75%.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP achieves leverage through margin borrowing. It has physical ownership of the underlying, and therefore does not use swaps or other derivatives to achieve its exposure. It does not have credit risk, because the Series has physical ownership of the underlying and does not use derivatives, like swaps, to achieve its leverage.

The Leverage Shares 3x Long Eli Lilly (LLY) is an exchange traded product, not an ETF. ETPs are structured as debt securities and lie outside the remit of UCITS. While not UCITS compliant, they may be UCITS eligible, meaning they are capable of being an eligible investment for another UCITS fund. It trades on exchange in the same way as a share.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP is designed for short term trading. It rebalances daily to maintain its 3x exposure to Eli Lilly and Company. Held for longer than one day, returns may differ from 3x the return of the underlying over that period, because of daily rebalancing and compounding.

Volatility decay is the effect of daily rebalancing and compounding on a leveraged product. When Eli Lilly and Company moves up and down repeatedly, compounding erodes value, and the effect is stronger the higher the leverage and the longer the holding period. This means the Leverage Shares 3x Long Eli Lilly (LLY) ETP can lose value over time even if the underlying ends up flat.

An investor in the Leverage Shares 3x Long Eli Lilly (LLY) ETP cannot lose more than the amount they invest. You could lose the full value of your investment if Eli Lilly and Company moves against the ETP by more than one-third (roughly 33%) in a single day. An intraday rebalance mechanism ("airbag") is designed to cushion the largest intra-day moves, triggering at 16.67%.

Yes. Alongside the Leverage Shares 3x Long Eli Lilly (LLY) ETP, the Leverage Shares -3x Short Eli Lilly (LLY) ETP (ISIN XS3068786972) provides -3x exposure to Eli Lilly and Company.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP does not pay dividends. It has physical ownership of the underlying, and any dividends received are reflected in the value of the ETP.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP is designed for short term trading, not long-term investing. Investing in Short and Leveraged ETPs is only suitable for sophisticated traders who understand leverage, daily rebalancing and compounded daily returns. Only use these ETPs if you can monitor your positions daily.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP is 100% backed with the underlying using a margin loan for long ETPs and with cash for short ETPs. Leverage Shares does not use derivatives, like swaps, to offer leveraged exposures.

Experienced investors may use the Leverage Shares 3x Long Eli Lilly (LLY) ETP for a variety of strategies. Some examples include responding to technical indicators, acting on earnings or news announcements, and hedging existing exposures in a portfolio. The recommended holding period is one day.

The Leverage Shares 3x Long Eli Lilly (LLY) ETP can be traded through brokerage accounts that have access to the exchanges where it is listed. It trades on the following exchanges, each with the ticker(s) to search on that exchange:

London Stock Exchange: LLY3 (USD), 3LLY (GBP)
Borsa Italiana: LLY3 (EUR)

Investors do not need a margin account in order to trade Leverage Shares ETPs.